Visit our new Alternative Investment section.Click here

Less Ads, More Data, More Tools Register for FREE

Poundland owner closing in on deal to buy Radley - report

Tue, 26th May 2026 11:27

(Sharecast News) - The owner of discount retailer Poundland is reportedly close to a deal to buy handbag maker Radley that will trigger another wave of retail job losses.

According to Sky News, Gordon Brothers - which specialises in distressed retail investments - could strike an agreement to buy Radley as early as Tuesday.

City sources told Sky that Radley was lining up the restructuring firm FTI Consulting as administrator with a view to completing a sale via a pre-pack administration of its brand and other intellectual property assets.

They said the deal was unlikely to include Radley's existing retail operations, meaning some job losses were inevitable. Sky said the size of Radley's workforce was unclear on Tuesday.

Radley was put up for sale earlier this year by private equity firm Freshstream, which has owned the brand for a decade.

Sky News revealed last month that Gordon Brothers was among the suitors for the business.

Related News

Ultimate Products appoints Princes Group's Simon Harrison as new CEO
1 hour ago

Ultimate Products appoints Princes Group's Simon Harrison as new CEO

(Sharecast News) - Ultimate Products said on Tuesday that it has appointed Princes Group's Simon Harrison as its new chief executive officer with effe...

Melrose shares fall after thermal incident prompts evacuations at GKN Aerospace site
4 hours ago

Melrose shares fall after thermal incident prompts evacuations at GKN Aerospace site

(Sharecast News) - Aerospace manufacturer Melrose Industries said on Tuesday that a thermal issue was identified last week at its GKN Aerospace facili...

Astrazeneca's Camizestrant cleared in the EU, Enhertu and Datroway pick up fresh recommendations
4 hours ago

Astrazeneca's Camizestrant cleared in the EU, Enhertu and Datroway pick up fresh recommendations

(Sharecast News) - Drugmaker Astrazeneca said on Tuesday that its breast cancer treatment camizestrant has secured EU approval, while its Enhertu and ...